Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Ando

Showing results (191-200 of 241) with videos related to

Pageof 25
Sort By:
Cancer Chemotherapy and Pharmacology|January 28, 2014
Phase 1 study of pazopanib alone or combined with lapatinib in Japanese patients with solid tumorsMegumi Inada-Inoue, Yuichi Ando, Kenji Kawada, et al.
Oncology Research and Treatment|September 13, 2021
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse EventsPatrick Schöffski, Nicole Concin, Cristina Suarez, et al.
Nagoya Journal of Medical Science|December 14, 2020
Chemotherapy for biliary tract cancer: real-world experience in a single instituteOsamu Maeda, Tomoki Ebata, Tomoya Shimokata, et al.
Asia-Pacific Journal of Clinical Oncology|February 11, 2016
Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinumMasashi Takano, Kaichiro Yamamoto, Tsutomu Tabata, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 19, 2025
Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitorsTsukasa Yasuda, Takanori Ito, Takuya Ishikawa, et al.
Contemporary Clinical Trials Communications|November 25, 2021
Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trialMitsuro Kanda, Dai Shimizu, Kazushi Miyata, et al.
International Journal of Clinical Oncology|June 20, 2026
Japanese clinical practice guidelines for pharmacotherapy in older adults with cancer (second edition): an overviewAyumu Matsuoka, Fumio Nagashima, Asao Ogawa, et al.
Life Science Alliance|March 3, 2022
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockadeYuki Miyai, Daisuke Sugiyama, Tetsunari Hase, et al.
Clinical and Experimental Nephrology|September 1, 2017
Guidelines for treatment of renal injury during cancer chemotherapy 2016Shigeo Horie, Mototsugu Oya, Masaomi Nangaku, et al.
Journal of Gastroenterology and Hepatology|October 27, 2022
Clustering using unsupervised machine learning to stratify the risk of immune-related liver injuryTakafumi Yamamoto, Hikaru Morooka, Takanori Ito, et al.
Pageof 25

Showing results (191-200 of 241) with videos related to

Sort By:
Pageof 25
Cancer Chemotherapy and Pharmacology|January 28, 2014
Phase 1 study of pazopanib alone or combined with lapatinib in Japanese patients with solid tumorsMegumi Inada-Inoue, Yuichi Ando, Kenji Kawada, et al.
Oncology Research and Treatment|September 13, 2021
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse EventsPatrick Schöffski, Nicole Concin, Cristina Suarez, et al.
Nagoya Journal of Medical Science|December 14, 2020
Chemotherapy for biliary tract cancer: real-world experience in a single instituteOsamu Maeda, Tomoki Ebata, Tomoya Shimokata, et al.
Asia-Pacific Journal of Clinical Oncology|February 11, 2016
Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinumMasashi Takano, Kaichiro Yamamoto, Tsutomu Tabata, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 19, 2025
Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitorsTsukasa Yasuda, Takanori Ito, Takuya Ishikawa, et al.
Contemporary Clinical Trials Communications|November 25, 2021
Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trialMitsuro Kanda, Dai Shimizu, Kazushi Miyata, et al.
International Journal of Clinical Oncology|June 20, 2026
Japanese clinical practice guidelines for pharmacotherapy in older adults with cancer (second edition): an overviewAyumu Matsuoka, Fumio Nagashima, Asao Ogawa, et al.
Life Science Alliance|March 3, 2022
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockadeYuki Miyai, Daisuke Sugiyama, Tetsunari Hase, et al.
Clinical and Experimental Nephrology|September 1, 2017
Guidelines for treatment of renal injury during cancer chemotherapy 2016Shigeo Horie, Mototsugu Oya, Masaomi Nangaku, et al.
Journal of Gastroenterology and Hepatology|October 27, 2022
Clustering using unsupervised machine learning to stratify the risk of immune-related liver injuryTakafumi Yamamoto, Hikaru Morooka, Takanori Ito, et al.
Pageof 25